Aethlon Medical Inc expected to post a loss of 8 cents a share - Earnings Preview

Aethlon Medical

11/02/2023 03:04

* Aethlon Medical Inc  AEMD.OQ   AEMD.O  is expected to show
a
rise in quarterly revenue when it reports  results on February
13. 
    * The San Diego California-based  company is expected to
report  a
18,556.9% increase in revenue to $3.172 million from $17
thousand a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Aethlon Medical Inc
is
for a loss of 8 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Aethlon
Medical
Inc is $8.5​, above​ its last closing price of $0.53. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022              -0.21      -0.18     Beat    16.3
 Jun. 30 2022  -0.22       -0.22      -0.19     Beat    13.6
 Mar. 31 2022              -0.14      -0.26     Missed  -85.7​
 Dec. 31 2021  -0.13       -0.13      -0.16     Missed  -23.1
 ​​Sep.        -0.17       -0.15      -0.13     Beat    13.3
 30 2021                                                
 Jun. 30 2021  -0.13       -0.13      -0.16     Missed  -23.1​
 Mar. 31 2021  -0.19       -0.20      -0.15     Beat    23.7
 Dec. 31 2020  -0.17       -0.16      -0.20     Missed  -21.2
 This summary was machine generated February 11 at 03:04 GMT. 
All figures in US dollars  unless otherwise stated